BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miller S, Daily L, Dharla V, Gertsch J, Malamas MS, Ojima I, Kaczocha M, Ogasawara D, Straiker A. Endocannabinoid metabolism and transport as targets to regulate intraocular pressure. Exp Eye Res 2020;201:108266. [PMID: 32979397 DOI: 10.1016/j.exer.2020.108266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Mincione F, Nocentini A, Supuran CT. Advances in the discovery of novel agents for the treatment of glaucoma. Expert Opin Drug Discov 2021;:1-17. [PMID: 33914670 DOI: 10.1080/17460441.2021.1922384] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Vallée A, Lecarpentier Y, Vallée JN. Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma. Int J Mol Sci 2021;22:3798. [PMID: 33917605 DOI: 10.3390/ijms22073798] [Reference Citation Analysis]
3 Bouskila J, Bleau M, Micaelo-Fernandes C, Bouchard JF, Ptito M. The Inhibition of the Degrading Enzyme Fatty Acid Amide Hydrolase Alters the Activity of the Cone System in the Vervet Monkey Retina. Brain Sci 2021;11:1418. [PMID: 34827417 DOI: 10.3390/brainsci11111418] [Reference Citation Analysis]
4 Gagestein B, Stevens AF, Fazio D, Florea BI, van der Wel T, Bakker AT, Fezza F, Dulk HD, Overkleeft HS, Maccarrone M, van der Stelt M. Chemical Proteomics Reveals Off-Targets of the Anandamide Reuptake Inhibitor WOBE437. ACS Chem Biol 2022;17:1174-83. [PMID: 35482948 DOI: 10.1021/acschembio.2c00122] [Reference Citation Analysis]
5 Chetoni P, Burgalassi S, Zucchetti E, Granchi C, Minutolo F, Tampucci S, Monti D. MAGL inhibitor NanoMicellar formulation (MAGL-NanoMicellar) for the development of an antiglaucoma eye drop. Int J Pharm 2022;:122078. [PMID: 35932931 DOI: 10.1016/j.ijpharm.2022.122078] [Reference Citation Analysis]
6 Jordan E, Nguyen GN, Piechot A, Kayser O. Cannabinoids as New Drug Candidates for the Treatment of Glaucoma. Planta Med 2022. [PMID: 35299275 DOI: 10.1055/a-1665-3100] [Reference Citation Analysis]